Morris Matthew Shawn 4

What Happened

• Matthew Morris, a director of Privia Health Group, exercised stock options and immediately sold the underlying shares. He exercised 7,788 options on 2026-02-26 and 16,550 options on 2026-02-27 (total 24,338 shares) at a $2.00 strike, paying $48,676 in exercise cost. He sold those shares in the open market the same days for total proceeds of $608,372 (weighted-average sale prices reported near $24.99–$25.00). The filing shows corresponding derivative dispositions at $0.00 reflecting cancellation of the options upon exercise.

Key Details

• Transaction dates: 2026-02-26 (7,788 shares) and 2026-02-27 (16,550 shares).
• Exercise prices / cost: $2.00 per share; total exercise cost $48,676.
• Sale proceeds: $194,622 (Feb 26) and $413,750 (Feb 27); total ≈ $608,372.
• Net proceeds (sales minus exercise cost): ≈ $559,696 (before taxes/fees).
• Weighted-average sale prices: ranges reported across multiple trades (≈ $24.95–$25.15 per share; see footnotes).
• Shares owned after the transactions: not disclosed in this Form 4.
• Footnotes: trades were effected pursuant to a Rule 10b5-1 trading plan; all stock options were fully vested and exercisable.
• Filing timeliness: Form 4 filed 2026-03-02 for transactions on 2026-02-26 and 02-27 — the filing appears timely under Form 4 rules.

Context

• This was an exercise-and-sell (cashless-like) transaction: options were exercised and the resulting shares were promptly sold in the open market. The presence of a 10b5-1 plan indicates the sales were made under a pre-established trading plan rather than ad hoc trading. Purchases (buying shares) tend to be more informative as bullish signals; here the net result was a cash-out by the insider rather than a new long purchase.